Genital Herpes Medical Services in China

Genital herpes, a chronic sexually transmitted infection caused by herpes simplex virus type 2 (HSV-2) — and less commonly HSV-1 — manifests as recurrent painful vesicular lesions on the penile shaft, glans, scrotum, or perianal region in males. Primary infection may present with systemic symptoms including fever, myalgia, and dysuria; subsequent recurrences are typically milder but can cause significant psychosocial distress, sexual dysfunction, and increased HIV transmission risk. While antiviral therapy (e.g., valacyclovir, famciclovir) effectively suppresses viral shedding and reduces outbreak frequency and severity, no current treatment eradicates latent viral reservoirs in dorsal root ganglia. Accurate diagnosis relies on PCR testing of lesion swabs or serologic assays for HSV-specific IgG antibodies. Long-term management emphasizes patient education, trigger avoidance, and individualized suppressive regimens.

China offers distinct advantages for international patients seeking comprehensive genital herpes care. Leading urology and dermatovenereology centers—such as Peking Union Medical College Hospital and Shanghai Ruijin Hospital—employ evidence-based protocols guided by national clinical guidelines and international standards. Advanced molecular diagnostics, real-time PCR quantification, and telemedicine-enabled follow-up ensure precision monitoring. Hundreds of documented cases demonstrate high adherence rates and sustained reduction in recurrence frequency with tailored antiviral regimens. Treatment costs in China are typically 40–60% lower than in the US, UK, or Germany, without compromising quality—generic and branded antivirals are rigorously regulated and widely available. As a dedicated medical tourism agency, we facilitate seamless access: verifying hospital credentials, coordinating appointments with certified urologists and infectious disease specialists, providing itemized, transparent pricing in advance, and offering end-to-end support—from visa assistance and accommodation to post-consultation follow-up coordination.

Treatment Options & Itemized Cost Breakdown: Genital Herpes (Urology/Andrology Department)

Non-Surgical / Conservative Management

*Target Criteria:* First episode, recurrent mild-moderate outbreaks (<6/year), immunocompetent adults.

• •Oral Antivirals (Per Course)

- *Valacyclovir 500 mg BID × 7 days*: $22–$32 - *Famciclovir 250 mg TID × 7 days*: $28–$40

• •Suppressive Therapy (Monthly)

- Valacyclovir 500 mg QD: $42–$62/month

• •Diagnostic & Monitoring Fees

- HSV-1/HSV-2 IgG serology (quantitative): $32–$45 - Urethral swab + culture (if atypical presentation): $55–$75 - Initial urology consultation (Grade 3A hospital): $18–$25

Surgical / Procedural Interventions

*Eligibility Criteria:* Refractory ulceration with necrosis, secondary bacterial superinfection unresponsive to IV antibiotics, or obstructive complications (e.g., urethral stricture from chronic scarring). *No routine surgical intervention for uncomplicated genital herpes.*

• •Debridement of Necrotic Ulcers (under local anesthesia)

• •Urethral Calibration + Biopsy (for suspected stricture)

• •Preoperative Workup (Mandatory)

- Urinalysis + urine culture: $22–$34 - Pre-anesthesia assessment (if sedation required): $35–$50

Special / Complex Condition Management

• •Immunocompromised Patients (e.g., HIV+, post-transplant)

- Extended oral suppression (valacyclovir 1 g BID): $85–$125/month

• •Primary Neonatal Exposure Risk (Partner management)

- Expedited partner notification & testing package: $75–$105

Quick Selection Guide

• •First Episode, Budget-Conscious (<$100 total): Acyclovir course + PCR swab ($60–$83)
• •Recurrent (4–6 outbreaks/year), Age <45, No Comorbidities: Valacyclovir suppressive therapy ($42–$62/month) + quarterly PCR monitoring ($48/visit)
• •HIV+ or Post-Chemotherapy: IV acyclovir admission ($180–$290) + monthly valacyclovir ($85–$125)
• •Chronic Ulceration + Painful Stricture: Urethral calibration + debridement ($330–$530 total, including pre-op labs)
• •Elderly (>70) with Renal Impairment: Dose-adjusted famciclovir + renal function monitoring ($35–$50/month drug + $22 lab)